Colorectal cancer in patients with inflammatory bowel disease

Parsia A. Vagefi, Walter E. Longo

Research output: Contribution to journalReview article

45 Citations (Scopus)

Abstract

Patients with inflammatory bowel disease (IBD) are subject to increased risks for the development of colorectal cancer (CRC), risks that are attributed to the duration and anatomic extent of disease in patients with ulcerative colitis and Crohn's disease. Although IBD contributes only 1%-2% to all cases of CRC, the mortality rate in patients with a diagnosis of CRC in the setting of IBD is higher than for those afflicted with sporadic cases of CRC. Given the length of time from IBD onset to the development of CRC, surveillance continues to be widely practiced. Although still under development, novel techniques for the earlier detection of dysplastic lesions have moved to the forefront in an attempt to optimize surveillance strategies and decrease the risk of CRC development.

Original languageEnglish (US)
Pages (from-to)313-319
Number of pages7
JournalClinical Colorectal Cancer
Volume4
Issue number5
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Inflammatory Bowel Diseases
Colorectal Neoplasms
Ulcerative Colitis
Crohn Disease
Mortality

Keywords

  • Crohn's disease
  • Epithelial dysplasia
  • Permanent ileostomy
  • Proctocolectomy
  • Surgical prophylaxis
  • Surveillance strategies
  • Ulcerative colitis

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Colorectal cancer in patients with inflammatory bowel disease. / Vagefi, Parsia A.; Longo, Walter E.

In: Clinical Colorectal Cancer, Vol. 4, No. 5, 01.2005, p. 313-319.

Research output: Contribution to journalReview article

@article{9bc738c6da43455cb702483de36a1c53,
title = "Colorectal cancer in patients with inflammatory bowel disease",
abstract = "Patients with inflammatory bowel disease (IBD) are subject to increased risks for the development of colorectal cancer (CRC), risks that are attributed to the duration and anatomic extent of disease in patients with ulcerative colitis and Crohn's disease. Although IBD contributes only 1{\%}-2{\%} to all cases of CRC, the mortality rate in patients with a diagnosis of CRC in the setting of IBD is higher than for those afflicted with sporadic cases of CRC. Given the length of time from IBD onset to the development of CRC, surveillance continues to be widely practiced. Although still under development, novel techniques for the earlier detection of dysplastic lesions have moved to the forefront in an attempt to optimize surveillance strategies and decrease the risk of CRC development.",
keywords = "Crohn's disease, Epithelial dysplasia, Permanent ileostomy, Proctocolectomy, Surgical prophylaxis, Surveillance strategies, Ulcerative colitis",
author = "Vagefi, {Parsia A.} and Longo, {Walter E.}",
year = "2005",
month = "1",
doi = "10.3816/CCC.2005.n.003",
language = "English (US)",
volume = "4",
pages = "313--319",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Colorectal cancer in patients with inflammatory bowel disease

AU - Vagefi, Parsia A.

AU - Longo, Walter E.

PY - 2005/1

Y1 - 2005/1

N2 - Patients with inflammatory bowel disease (IBD) are subject to increased risks for the development of colorectal cancer (CRC), risks that are attributed to the duration and anatomic extent of disease in patients with ulcerative colitis and Crohn's disease. Although IBD contributes only 1%-2% to all cases of CRC, the mortality rate in patients with a diagnosis of CRC in the setting of IBD is higher than for those afflicted with sporadic cases of CRC. Given the length of time from IBD onset to the development of CRC, surveillance continues to be widely practiced. Although still under development, novel techniques for the earlier detection of dysplastic lesions have moved to the forefront in an attempt to optimize surveillance strategies and decrease the risk of CRC development.

AB - Patients with inflammatory bowel disease (IBD) are subject to increased risks for the development of colorectal cancer (CRC), risks that are attributed to the duration and anatomic extent of disease in patients with ulcerative colitis and Crohn's disease. Although IBD contributes only 1%-2% to all cases of CRC, the mortality rate in patients with a diagnosis of CRC in the setting of IBD is higher than for those afflicted with sporadic cases of CRC. Given the length of time from IBD onset to the development of CRC, surveillance continues to be widely practiced. Although still under development, novel techniques for the earlier detection of dysplastic lesions have moved to the forefront in an attempt to optimize surveillance strategies and decrease the risk of CRC development.

KW - Crohn's disease

KW - Epithelial dysplasia

KW - Permanent ileostomy

KW - Proctocolectomy

KW - Surgical prophylaxis

KW - Surveillance strategies

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=14644429135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14644429135&partnerID=8YFLogxK

U2 - 10.3816/CCC.2005.n.003

DO - 10.3816/CCC.2005.n.003

M3 - Review article

C2 - 15663834

AN - SCOPUS:14644429135

VL - 4

SP - 313

EP - 319

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 5

ER -